Chemomab Therapeutics Ltd. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents
Chemomab Therapeutics Ltd. (CMMB) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents of $2.43 million as of 2021-03-16, per its 20-F filed 2024-03-28.
Discontinued › Notes › Business Combination, Recognized Asset Acquired, Asset, Current
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents · last filed 2024-03-28
- 2021-03-16: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents $2.43M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents |
|---|---|
| 2021-03-16 | $2.43M 20-F · filed 2024-03-28 |